Location: Home
  • search
  • go
  • Relate News
  • 9/24/2019Caixin: Dr Reddy’s Is First Indian Drugmaker Accepted by China's 4+7 ...
  • 9/24/2019Bloomberg: China’s Drug-Price Cuts Pressure Lipitor and Other Foreign...
  • 9/24/2019China Expands 4+7 Drug Trial, Putting More Pressure on Pharma Cos
  • 9/23/2019Xynomic Pharma Wins FDA Fast-Track Designation of Abexinostat for Foll...
  • 9/23/2019China to Promote Medical and Senior Care Integration
  • 9/23/2019Big Pharma Seen Unlikely To Gain From China's Revised Drug Purchase Po...
  • 9/20/2019Recent Executive Moves
  • 9/20/2019Advanced Aesthetic Technologies and CNBG Announce Strategic Cooperatio...
  • 9/20/2019Shanghai Pharma and BIOCAD to Set Up $400M Joint Venture
  • 9/20/2019MicuRx Reports Positive Top-line Results of a China Phase 3 Trial for ...
  • 9/19/2019China Biologic Receives $4.6 Billion Buyout Offer
  • 9/17/2019Medtech The Most-Invested Sector in China Recently
  • 9/17/2019Listed Chinese Pharma Companies Report H1/2019 Performance
  • 9/17/201915 Leading Chinese Pharma Companies Maintains High R&D Investment ...
  • 9/17/2019IQVIA: Chinese Hospital Drug Market Up 7.6% in MAT Q2/2019
  • 9/17/2019NMPA Solicits Comments on Proposed List of Drug Regulatory Certificati...
  • 9/16/2019China to Raise BMI Reimbursement of Outpatient Diabetes and Hypertensi...
  • 9/16/2019China Begins Mapping Standards for 5G-based Hospitals
  • 9/15/2019Biocon, CMS Enter Licensing Deal to Sell Three Drugs in China
  • 9/15/2019Recent Executive Moves
  • 9/11/2019Hansoh Atomwise Launch Strategic AI Drug Discovery Collaboration for M...
  • 9/11/2019China Announces Tariff Exemptions on U.S Goods Including Anticancers
  • 9/9/2019Chinese Vitamin C Price-Fixing Case Could Alter U.S. Drug Market
  • 9/9/2019India, China Agree to Promote Pragmatic Cooperation in Pharma Sector
  • 9/9/2019CPA Releases Announcement for Excessively-Supplied Drug Products (5th ...
  • 9/9/2019Sales Expenditures of Chinese Pharma Cos Continued to Grow in H1/2019
  • 9/9/2019J&J's Prostate Cancer New Drug Approved in China
  • 9/9/2019Sumitomo Dainippon Launches Antipsychotic Latuda in China:
  • 9/6/2019Recent Executive Moves
  • 9/6/2019PAG Acquires Hisun's Biosimilars Arm BioRay for CNY 3.8B
  • Page:109/334 Total number of articles:9993: [First][<<] [107] [108] [109] [110] [111] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group